Agenda

This discussion will highlight the importance of diverse and interoperable data in driving progress and show how shared infrastructure and collaborative approaches to research transform fragmented data into key insights. This discussion will include a strong focus on the S|GN Consortium.

This spotlight discussion will focus on the evolution of AD detection over the different stages, the progression of the DxA focus to align with the shift in the field and utilizing DxA 3.0 to leverage the advancing diagnostic technologies and AI capabilities. These advances will continue to push the envelope to capture disease heterogeneity and expand to other contexts of use to get a better picture of an individual’s disease trajectory and therapeutic response.

This panel discussion highlights the value of moving beyond amyloid-centric frameworks to capture the biological complexity underlying disease heterogeneity, focusing on efforts to date, strategies for leveraging existing datasets, key challenges, and paths forward to enable the next generation of diagnostics.

Five finalist teams present their agentic AI solutions designed to accelerate Alzheimer's and related dementias research. Each team demonstrates scalable, interoperable approaches that align with the Alzheimer's Disease Data Initiative's platforms and mission to serve the public good.

This spotlight talk will highlight current updates for SpeechDx projects

This panel discussion will focus on the earliest points of intervention and the importance of representative, multimodal data. The panel will discuss key topics related to leveraging AI for the development of digital tools for AD, biology of risk & resilience, the role of speech, eye tracking, sleep, behavior, active/passive digital and other biomarkers in early detection, and translating population level insights into individual recommendations.